Development of high‐throughput and high sensitivity capillary gel electrophoresis platform method for Western, Eastern, and Venezuelan equine encephalitis (WEVEE) virus like particles (VLPs) purity determination and characterization
Abstract
In this paper, we describe development of a high‐throughput, highly sensitive method based on Lab Chip CGE‐SDS platform for purity determination and characterization of virus‐like particle (VLP) vaccines. A capillary gel electrophoresis approach requiring about 41 s per sample for analysis and demonstrating sensitivity to protein initial concentrations as low as 20 μg/mL, this method has been used previously to evaluate monoclonal antibodies, but this application for lot release assay of VLPs using this platform is unique. The method was qualified and shown to be accurate for the quantitation of VLP purity. Assay repeatability was confirmed to be less than 2% relative standard deviation of the mean (% RSD) with interday precision less than 2% RSD. The assay can evaluate purified VLPs in a concentration range of 20–249 μg/mL for VEE and 20–250 μg/mL for EEE and WEE VLPs.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 20, 2017
- Source ID
- 10.1002/elps.201700217
Entities
People
- Deepika Gollapudi
- Diane L Wycuff
- Jonathan W Cooper
- Kc Cheng
- Richard M. Schwartz
Organizations
- AbbVie
- National Institutes of Health
- United States Department of Defense